Hematopoietic stem-cell transplantation using umbilical-cord blood cells

Revista de Investigacion Clinica

Volumn 57, Issue 2, 2005, Pages 314-323

  Rocha, Vanderson ^a   Garnier, Federico ^a   Ionescu, Irina ^a   Gluckman, Eliane ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD COMPATIBILITY; BLOOD DONOR; BONE MARROW DISEASE; CANCER MORTALITY; CANCER SURVIVAL; CHILDHOOD DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; FEASIBILITY STUDY; FOLLOW UP; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA RELAPSE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FORECASTING; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HUMANS; INFECTION; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 25444503780     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-8.
2. Wernet P. The Netcord inventory and use. July 12, 2002. Accessed and available January 11, 2005 at: http://office.de.netcord.org/inventory.gif
3. Barker JN, Krepski TP, DeFor T, et al. Searching for unrelated donor hematopoietic stem-cell grafts: availability and speed of umbilical-cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257-60.
4. Dalle JH, Duval M, Moghrabi A, et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33: 605-11.
5. Davey S, Armitage S, Rocha V, et al. The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Haematol 2004; 125: 358-65.
6. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-81.
7. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000; 342: 1846-54.
8. Locatelli F, Rocha V, Reed W, et al. Related umbilical-cord blood transplant in patients with Thalassemia and Sickle Cell Disease. Blood 2003; 101: 2137-43.
9. Michel G, Rocha V, Chevret S, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003; 101: 351-7.
10. Reed W, Smith R, Dekovic F, et al. Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease. Blood 2003; 102: 4290-7.
11. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-77.
12. Ohnuma K, Isoyama K, Nishihira H. Cord blood transplantation from HLA-mismatched unrelated donors. Leuk Lymphoma 2002; 43: 1029-43.
13. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem-cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157-66.
14. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical-cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-18.
15. Styczynski J, Cheung YK, Garvin J, et al. Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 2004; 34: 129-36.
16. Yu LC, Wall DA, Sandler E, et al. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium. Pediatr Hematol Oncol 2001; 18: 235-45.
17. Staba SL, Escolar ML, Poe M, et al. Cord blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960-9.
18. Benito AI, Diaz MA, Gonzalez-Vincent M, et al. Hematopoietic stem-cell transplantation using umbilical-cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004; 33: 675-90.
19. Gluckman E, Rocha V, Arcese W, et al. Eurocord Group. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407.
20. Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical-cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717-22.
21. Iori AP, Cerretti R, De Felice L, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing unrelated cord blood transplantation. Bone Marrow Transplant 2004; 33: 1097-105.
22. Stevens CE, Gladstone J, Taylor PE, et al. Placental/umbilical-cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood 2002; 100: 2662-4.
23. Rocha V, Cornish J, Sievers E, et al. Comparison of outcomes of unrelated bone marrow and umbilical-cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-71.
24. Barker JN, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical-cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957-61.
25. Sanz G, Rocha V. Umbilical-cord blood transplantation: current status and future directions. Curr Opin Organ Transpl 2003; 8: 109-17.
26. Moscardo F, Sanz GF, Sanz MA. Unrelated-donor cord blood transplantation for adult hematological malignancies. Leuk Lymphoma 2004; 45: 11-8.
27. Koh LP, Chao NJ. Umbilical-cord blood transplantation in adults using myeloablative and non-myeloablative preparative regimens. Biol Blood Marrow Transplant 2004; 10: 1-22.
28. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-22.
29. Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001; 98: 2332-8.
30. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103: 489-91.
31. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003; 101: 4711-3.
32. Long GD, Laughlin M, Madan B, et al. Unrelated umbilical-cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003; 9: 772-80.
33. Rocha V, Arcese W, Sanz G, et al. Prognostic factors of outcome after unrelated cord blood transplant in adults with hematological malignancies. Blood 2000; 96: 587a (abstract).
34. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematological malignancies. Blood 2004; 104: 3813-20.
35. Rocha V, Labopin M, Sanz G, et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-85
36. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-75.
37. Niehues T, Rocha V, Filipovich A, et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis. Br J Haematol 2001; 114: 42-8.
38. Ballen K, Broxmeyer HE, McCullough J, et al. Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant 2001; 7: 635-45.
39. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368-76.
40. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical-cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the Aastrom Replicell System. Blood 2003; 101: 5061-7.
41. McNiece I. Ex vivo expansion of hematopoietic cells. Exp Hematol 2004; 32: 409-10.
42. Peled T, Landau E, Mandel J, et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 2004; 32: 547-55.
43. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001; 344: 1870-1.
44. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, et al. Transplantation of 2 partially HLA-matched umbilical-cord blood units to enhance engraftment in adults with hematological malignancy. Blood 2005; 105: 1343-7.
45. Hamsa NS, Fanning L, Tary-Lehmann M, et al. High rate of graft failure after infusion of multiple (3-5) umbilical-cord blood (UCB) units in adults with hematological disorders: role of HLA disparity and UCB graft cell cross immune reactivation. Blood 2003; 98(abstract).
46. Fernandez MN, Regidor C, Cabrera R, et al. Unrelated umbilical-cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31: 535-44.
47. Kim DW, Chung YJ, Kim TG, et al. Co transplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103: 1941-8.
48. Mazurier F, Doedens M, Gan OI, et al. Rapid myelo erythroid repopulation after intra femoral transplantation of NOD-SCID mice reveals a new class of human stem-cells. Nat Med 2003; 9: 959-63.
49. Castello S, Podesta M, Menditto VG, et al. Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol 2004; 32: 782-7.
50. Hagglund J. et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant 1998; 21: 331-51.
51. Barker JN, Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical-cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-9.
52. Chao NJ, Koh LP, Long GD, et al. Adult recipients of umbilical-cord blood transplants after non-myeloablative preparative regimens. Biol Blood Marrow Transplant 2004; 10: 569-75.
53. Del Toro G, Satwani P, Harrison L, et al. A pilot study of reduced intensity conditioning and allogeneic stem-cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613-22.
54. Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem-cell transplantation. Blood 2002; 99: 1458-64.
55. Montagna D, Locatelli F, Moretta A, et al. T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation. Blood 2004; 103: 4322-9.
56. Klein AK, Patel DD, Gooding ME, et al. T-cell recovery in adults and children following umbilical-cord blood transplantation. Biol Blood Marrow Transplant 2001; 7: 454-66.
57. Hamsa NS, Lisgaris M, Yadavalli G, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical-cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004; 124: 488-98.
58. Barker JN, Martin PL, Coad JE, et al. Low incidence of Epstein-Barr virus-associated post transplantation lymphoproliferative disorders in 272 unrelated-donor umbilical-cord blood transplant recipients. Biol Blood Marrow Transplant 2001; 7: 395-9.
59. Sashihara J, Tonaka-Taya K, Tanaka S, et al. High incidence of human herpes virus 6 infection with a high viral load in cord blood stem-cell transplant recipients. Blood 2002; 100: 2005-11.
60. Tomonari A, Iseki T, Takahashi S, et al. Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation. Ann Hematol. [in press]
61. Tomonari A, Takahashi S, Iseki T, et al. Herpes simplex virus infection in adult patients after unrelated cord blood transplantation: a single-institute experience in Japan. Bone Marrow Transplant 2004; 33: 317-20.
62. Tomonari A, Iseki T, Takahashi S, et al. Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol 2003; 122: 802-5.